McKesson streamlines after COVID-19

Shares of drug wholesaler McKesson have surged over 270% in the past five years. That’s largely due to its deal with the U.S. government to distribute COVID-19 vaccines. Even though the pandemic has eased, the company should continue to benefit from its plan to narrow… Read More